News
One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...
Sarepta owns a trio of injectable medicines for various forms of DMD. One thing that should make Sarepta bulls feel comfortable is that even the most conservative price targets on the Street imply ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback